Wed.Feb 28, 2024

article thumbnail

Opinion: Medicare Advantage is bad for patients and bad for investors

STAT

In 2023, enrollment in Medicare Advantage, the version of Medicare run by private insurers, surpassed 50% of eligible beneficiaries for the very first time. Going by this headline, or perhaps the predictable flood of advertisements for plans during the fall’s open enrollment period, you might be fooled into thinking 2023 was MA’s best year yet.

363
363
article thumbnail

How to Cite Videos, Podcasts, Apps, Media, and Blogs in a Publication or CV (AMA style 11th edition)

ALiEM - Pharm Pearls

As medical education podcasts, videos, and blogs continue to grow in popularity it is crucial that we cite them correctly, both in publications and on our CVs. We also must recognize the important contributions of media such as clinical photographs, radiology images, and ECGs. The American Medical Association (AMA) Manual of Style released its 11th edition in 2020.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘Brain fog’ is one of Covid-19’s most daunting symptoms. A new study measures its impact

STAT

Of all the lingering symptoms of long Covid , difficulty focusing and thinking, known as brain fog , may be the most frightening and baffling. A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 363
article thumbnail

Can a top scientist and Moderna co-founder change the CRO game?

PharmaVoice

From his advisory board role at Lindus Health, Robert Langer is aiming to overcome challenges in the CRO market.

148
148
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Why won’t Medicare deliver food to sick seniors, if it could get them healthy?

STAT

WASHINGTON – Some twelve percent of traditional Medicare beneficiaries have heart failure. Roughly a quarter have diabetes. There’s early evidence suggesting that both conditions — and a slew of others — could be better managed with pre-made healthy meals. So why doesn’t Medicare try out delivering food to sick seniors?

Diabetes 359
article thumbnail

A pandemic-era staffing crunch in clinical trials is easing, but trouble spots remain

PharmaVoice

How research companies can shift strategies to attract and retain the staff that keeps trials humming along.

148
148

More Trending

article thumbnail

Power of digital technology and partnership to accelerate delivery of new medicines to patients

pharmaphorum

Discover how digital technology and strategic partnerships are revolutionising the pharmaceutical industry, enabling faster delivery of life-saving medicines to patients, while advancing humanity's fight against diseases.

115
115
article thumbnail

Q&A: The scientific integrity sleuth taking on the widespread problem of research misconduct

STAT

Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives. An authority on scientific image analysis who’s been profiled in The New Yorker for her unique ability to spot duplicated or doctored photographs, she appeared frequently in the news over the past year as one of the experts who raised research misconduct concerns that led to an investigation into, and the eventual departure of, former Stanford president Marc Tessier-Lavig

360
360
article thumbnail

Beacon Therapeutics unveils promising interim results for gene therapy AGTC-501

Pharmaceutical Technology

AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space

122
122
article thumbnail

Meet the contenders for the STAT Madness 2024 crown. Voting begins March 1

STAT

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers. STAT Madness is our annual bracket-style competition in which readers vote on the most important and impactful biomedical and health research published in the past year by scientists at universities and independent labs

356
356
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData

Express Pharma

Following the news that the FDA denied approval for Minerva Neurosciences for its roluperidone for the treatment of negative symptoms in patients with schizophrenia; Christie Wong, Neurology Analyst at GlobalData, offers her view: “The FDA has issued a Complete Response Letter (CRL) for Minerva Neurosciences’ roluperidone. It follows a refusal to file in October 2022 and two FDA Type C meetings in November 2020 and March 2022.

115
115
article thumbnail

STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry. It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic.

article thumbnail

AbbVie inks $713m deal for OSE chronic inflammation drug

pharmaphorum

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics. There’s another $665 million in potential milestones and a royalty tied to the deal, which focuses on OSE-230, billed as a potentially first-in-class activator of ChemR23, a G-protein coupled receptor (GPCR) found on some white blood cells.

112
112
article thumbnail

Amid measles outbreaks, U.K. launches vaccination ad campaign to boost childhood immunizations

STAT

LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. The campaign, starting March 4, features children talking about their lack of protection from infections like measles and whooping cough if they’re not vaccinated.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Rare Disease Day: Enhancing clinical trial success in rare diseases

pharmaphorum

Rare Disease Day is an opportunity to highlight the importance of enhancing clinical trial success in rare diseases for the benefit of patients.

119
119
article thumbnail

Chikungunya vaccine approved for select groups by CDC advisory panel

STAT

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH. It will become U.S. vaccination policy when Mandy Cohen, director of the Centers for Disease Control and Prevention, signs off on the recommendation from th

Vaccines 291
article thumbnail

ICR study reveals new targeted immunotherapy to prevent spread of breast cancer

Pharma Times

Breast cancer is responsible for around 47,000 new cases in England every year

146
146
article thumbnail

STAT+: Pharmalittle: We’re reading about the FTC vs. PBMs, FDA adcomm voting and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Younger pharmacists want to work in multiple settings, says PCPA president

The Pharmacist

The new generation of pharmacists will not be satisfied with the ‘status quo’ of working in just one sector, Primary Care Pharmacy Association (PCPA) president Graham Stretch warned a community pharmacy conference this week. He warned contractors that younger pharmacists would ‘force our hands’ into creating multi-sector working opportunities. And he said that providers would […] The post Younger pharmacists want to work in multiple settings, says PCPA president appeared first on The Pharm

article thumbnail

Biden ‘continues to be fit for duty,’ his doctor says, after president undergoes annual physical

STAT

BETHESDA, Md. — President Joe Biden  “continues to be fit for duty,” his doctor wrote Wednesday after conducting an annual physical that is being closely watched as the 81-year-old  seeks reelection  in November. Dr. Kevin O’Connor, Biden’s physician, wrote that the president is adjusting well to a new device that helps control his sleep apnea and has experienced some hip discomfort but also works out five times per week.

282
282
article thumbnail

Basic cleaning and sanitation practices in Pharmaceuticals

GMPSOP

Basic cleaning and sanitation practices in Pharmaceuticals Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST Cleaning and sanitation of pharmaceutical equipment and facilities account for almost one-third of all production activities, if not more. Uncompromised safety and efficacy of pharmaceutical products are the best outcomes for the patients.

article thumbnail

Beam is trading like it’s 2021

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a resurgence in psychiatric drug development, a big day for biotech stocks, and some innovation in the world of quarterly earnings.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

The implementation of the EU’s Health Technology Assessment Regulation (HTAR) 1 will play a key role in shaping the patient access pathway for ATMPs such as cell and gene therapies. This is a great opportunity for healthcare systems in Europe to benefit from the latest therapeutic innovations which can offer life-changing outcomes to those suffering from debilitating conditions.

97
article thumbnail

PHTI to review digital hypertension, mental health tools

pharmaphorum

Peterson Health Technology Institute will review the clinical effectiveness and economic impact of digital health technologies (DHTs) for hypertension and mental health.

106
106
article thumbnail

Implications of AI regulation for data integrity

European Pharmaceutical Review

A study published in the Asian Journal of Advanced Research and Reports , has reported “a strong positive correlation between higher levels of regulatory compliance and perceived effectiveness in artificial intelligence (AI) implementation, as well as between AI ethics awareness and data integrity assurance.” The research highlighted the importance of regulatory frameworks and professional training in shaping AI development, specifically “dynamic, adaptable, and inclusive regulatory frameworks t

97
article thumbnail

Zeno Health secures $25 million in Series C funding

Express Pharma

Zeno Health, an omnichannel platform for generic medicines, announced the successful closure of its Series C funding round, securing a total of $5 million. The round has been led by Korean private equity investor STIC Investments. Existing Zeno Health investor Lightbox was also a significant participant in the round. The company informed that the $25 million capital injection will be pivotal in propelling Zeno Health’s initiatives to reach more consumers, expand its footprint, and further

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Viatris splashes out $350m on pair of Idorsia therapies

pharmaphorum

Viatris licenses two late-stage drugs from Idorsia for heart attack and lupus, both claimed to have blockbuster sales potential, for $350m upfront.

110
110
article thumbnail

Innovations paving the way for drug discovery of rare diseases

Express Pharma

Orphan diseases, also known as rare diseases, are a variety of conditions that affect a small percentage of the population. By definition, rare diseases are those diseases with a prevalence rate of one case in a population of 10,000 people. Rare diseases are of two types: primary and secondary. Primary rare diseases are caused due to genetic or congenital defects.

article thumbnail

Janux plans $200m offer on back of prostate cancer readout

pharmaphorum

Buoyed by data from a trial of its T-cell engager (TCE) therapy in prostate cancer that almost tripled its share price, Janux Therapeutics has moved quickly to file a stock offering that could add around $200 million to its cash position. The San Diego biotech is offering $175 million in a public offering that could rise to $201.5 million if underwriters take up an option, less discounts and commissions.

96
article thumbnail

Call for local ‘collaborative’ primary care contract 

The Pharmacist

Community pharmacies, GP practices and dentists should work together to create a ‘single collaborative local contract’ based on local health outcomes, the president of the National Association of Primary Care (NAPC) has suggested. At a local level, Ash Soni said primary care providers should ‘think creatively’ with their integrated care system (ICS) to propose ways […] The post Call for local ‘collaborative’ primary care contract appeared first on The Pharmacist.

article thumbnail

Pelage secures funds to develop regenerative medicine for hair loss

Pharmaceutical Technology

Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405 for hair loss.

104
104